Atypical Parkinson syndromes. What is the clinical picture and treatment of atypical Parkinson syndromes?
For differentiating between atypical Parkinson syndromes, and to differentiate them from Parkinson's disease is important not only knowledge of the department of diseases but also to follow the development of symptoms, especially during the first four years, as
many of the symptoms or close to them can occur at different rates in several diseases.
dementia with Lewy bodies - clinical disease overlap with Alzheimer's and Parkinson's disease. In half of these cognitive disorders are onset, and the rest to be diagnosed with dementia with Lewy bodies dementia must be developed in 1-3 years. Parkinsonism developed in 80% of patients. Cognitive disorders fluctuate include changes in attention and alertness. Fluctuations may be accompanied by somnolence and still minutes to months. Typical are the mental symptoms such as delusions, repetitive visual hallucinations not related to medications. Parkinsonism is symmetrical, akinetichen, rigid and tremor is less covers. (Tremor rest 27-55%). Dysarthria, dysphagia, falls occur more frequently than in Parkinson's disease. Additional signs were apraxia, aphasia, impaired visual-spatial orientation, akalkuliya, agnoziya, syncope, transient loss of consciousness and hallucinations nezritelni. Up to 87% of patients with dementia with Lewy bodies have a good response to dopaminergic therapy. Recommended the use of L-dopa with COMT inhibitors. Cognitive disorders are treated with cholinesterase inhibitors, visual hallucinations 50 mg clozapin, orthostatic hypotension - with sympathomimetics. Due to the risk of hallucinations are looking for low doses of L-dopa and dopamine agonists are used.
multisystem atrophy - the disease is characterized by parkinsonism, cerebellar together, autonomous and other atypical features. Describe the two forms of the disease: MSA-P - 80% of patients with predominant parkinsonism and MSA-C with dominant cerebellar ataxia. Affects both men and women from 33 to 78 years, median age 54 years. Life expectancy is 6-9 years. Parkinsonian symptoms are mainly bradykinesia, rigidity, postural tremor, tremor at rest (34%), loss of balance, unsteady gait. Established in about 90% of patients. In 27-56% onset is asymmetric. Manifestations are cerebellar ataxia, dysarthria, okulomotorni interference. Is found in 50% of patients. Autonomous and pyramidal disorders develop in almost all patients. Autonomous distortions are mainly orthostatic hypotension, erectile dysfunction, decreased genital sensitivity in women, constipation, hypo to anhydrous, urinary incontinence or retention. Pyramid signs are mild - Babinska reflex, hyperreflexia psevdobulbarna paresis. Additionally you can monitor sleepy, cognitive impairment, depression and others. The response to treatment with L-dopa e 69-75%, but rapidly decreasing, 35% remained partially sensitive. There are no effective medical treatment. Hypotension may be affected by fluid intake and NaCl, more frequent meals.
Progressive Supranuclear Palsy - the disease is present with early postural netabilnost and falls, vertical look Supranuclear paresis, frontal subcortical dementia and parkinsonism with bradykinesia and pronounced axial rigidity, eotgovaryasht of L-dopa treatment. Patients with Progressive Supranuclear Palsy are homozigoti in H1 tau haplotip. The disease affects twice as common men. Describe the relationship between Progressive Supranuclear Palsy and neurotoxic substances. Tobacco and coffee are protective factors. Progressive Supranuclear Palsy develops in the sixth or seventh decade, never before 40 years, an average of 58 years. Patients live 2 to 12 years to 24 years casuistic, death occurred an average of 5 years and is caused by hipostatichna pneumonia. Seen paresis usually develops after 3 years, most often preceded by a slowing of vertical sakadi. Specific clinical syndromes are psevdobulbarnata paralysis preoccupation, lack of flash and sitting "en block". In rare are pyramidal and cerebellar syndromes. Static tremor occurs in 17%. Dementia is characterized by impaired memory, difficulty in planning, apathy or irritability.
kortikobazalna dystrophy - a slowly progressive disorder with onset in adulthood, characterized by degeneration of the basal ganglia and cortex. The disease does not start before '45 and affects both sexes equally. Median survival is 7-8 years, death occurs from aspiration pneumonia or sepsis. There are two phenotypes with different anatomical part. The disease is associated with H1/H1 tau phenotype. It is characterized by the combination of motor and perceptual disturbances. Approximately 50% of cases the disease presents with asymmetric parkinsonism, dystonia, limb apraxia, myoclonus, and possibly neglekt syndrome "alienated" limb. Possible early speech, but without swallowing disorders. In other patients are possible aphasia, disturbances in attention, behavior disorders of frontal type and other cognitive symptoms. Possible incontinence, bilateral pyramidal or Parkinson interference. Parkinsonism is not affected by L-dopa and 95% of cases begins asymmetrically.
No comments:
Post a Comment